NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Telo Genomics Corp (F: 3D0A)

 
3D0A Technical Analysis
5
As on 20th Nov 2024 3D0A STOCK Price closed @ 0.03 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.12 & Strong Sell for SHORT-TERM with Stoploss of 0.16 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

3D0ASTOCK Price

Open 0.03 Change Price %
High 0.03 1 Day -0.04 -57.14
Low 0.03 1 Week -0.03 -50.00
Close 0.03 1 Month -0.01 -25.00
Volume N/A 1 Year -0.15 -83.33
52 Week High 0.18 | 52 Week Low 0.03
 
F Germany Most Active Stocks
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
ENB 47.60 -0.92%
TEF 3.84 -0.52%
TEF 3.84 -0.52%
WHL 5150.00 -0.44%
WDI 0.05 -37.50%
 
F Germany Top Gainers Stocks
JYR 1000000.00 10000000000.00%
JYR 1000000.00 10000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
0AI 11.30 14025.00%
0AI 11.30 14025.00%
SUE1 12.60 12500.00%
HGF2 7.40 1380.00%
 
F Germany Top Losers Stocks
CMID 0.00 -100.00%
CMID 0.00 -100.00%
CMID 0.00 -100.00%
3MW 0.00 -100.00%
3MW 0.00 -100.00%
BRTN 0.00 -100.00%
BRTN 0.00 -100.00%
2TU 0.00 -100.00%
TINC 0.01 -99.92%
TINC 0.01 -99.92%
 
 
3D0A
Daily Charts
3D0A
Intraday Charts
Whats New @
Bazaartrend
3D0A
Free Analysis
 
3D0A Important Levels Intraday
RESISTANCE0.03
RESISTANCE0.03
RESISTANCE0.03
RESISTANCE0.03
RESISTANCE0.03
RESISTANCE0.03
RESISTANCE0.03
RESISTANCE0.03
 
3D0A Forecast November 2024
4th UP Forecast0.13
3rd UP Forecast0.1
2nd UP Forecast0.08
1st UP Forecast0.06
1st DOWN Forecast0
2nd DOWN Forecast-0.02
3rd DOWN Forecast-0.04
4th DOWN Forecast-0.07
 
3D0A Weekly Forecast
4th UP Forecast0.07
3rd UP Forecast0.06
2nd UP Forecast0.05
1st UP Forecast0.04
1st DOWN Forecast0.02
2nd DOWN Forecast0.01
3rd DOWN Forecast0.00
4th DOWN Forecast-0.01
 
3D0A Forecast2024
4th UP Forecast0.32
3rd UP Forecast0.23
2nd UP Forecast0.17
1st UP Forecast0.11
1st DOWN Forecast-0.05
2nd DOWN Forecast-0.11
3rd DOWN Forecast-0.17
4th DOWN Forecast-0.26
 
 
3D0A Other Details
Segment EQ
Market Capital 17545378.00
Sector Healthcare
Industry Diagnostics & Research
Offical website >
 
3D0A Address
3D0A
 
3D0A Latest News
 
Your Comments and Response on Telo Genomics Corp
 
3D0A Business Profile
Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions. It provides telomere analysis platform with diagnostic and prognostic applications; and solutions with liquid biopsies and related technologies in oncology and neurological diseases. The company's lead application is Telo-MM, a solution that provides actionable information to medical professionals in the treatment of Multiple Myeloma, a form of blood cancer. Its solutions also include TeloView, a proprietary software platform used to quantify specific features of each patient's telomeres. The company serves pathologists, clinicians, academic researchers, and drug developers. Telo Genomics Corp. has a collaboration agreement with the Mayo Clinic to validate its Telo-MM tests for multiple myeloma. The company was formerly known as 3D Signatures Inc. and changed its name to Telo Genomics Corp. in April 2019. Telo Genomics Corp. was incorporated in 2011 and is headquartered in Toronto, Canada. Address: MaRS Centre, Toronto, ON, Canada, M5G 1L7
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service